{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T04:31:02Z","timestamp":1789446662824,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T00:00:00Z","timestamp":1691539200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T00:00:00Z","timestamp":1691539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Polycystic ovary syndrome (PCOS) is one of the most frequent endocrine disorders among women of fertile age. Women with PCOS manifest clinical symptoms like menstrual dysfunction, hirsutism, insulin resistance, and hyperinsulinemia. As excessive amounts of insulin levels directly increase ovarian production of androgens, hyperinsulinemia and insulin resistance are considered as the pathogenesis factors of PCOS. The portfolio low-carbohydrate diet (PLCD) is a plant-based diet with 40% carbohydrates combined with five cholesterol-lowering foods and nutrients. On the other hand, the ketogenic diet (KD) is a nutritional protocol with 10% carbohydrates. The purpose of this study is to determine whether PLCD or KD is more effective in alleviating PCOS symptoms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Forty-six overweight or obese women diagnosed with PCOS will be randomly stratified to receive either PLCD or KD for 8\u00a0weeks. Measures related to anthropometric and body composition, glucose, and insulin level, HOMA-IR, sex hormones, lipid profile, quality of life, dietary intake, physical activity, and Ferriman-Gallwey score of all participants will be accessed before and after the intervention.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>Since the first line treatment of PCOS is lifestyle adjustment including diet control and exercise, there has not been determined the optimal diet for this population of women yet. Hence, the goal of conducting this study is to determine whether the PLCD or the KD could have more advantageous effects on attenuating PCOS manifestations. The result of this investigation will give us new insight into curing this disease and will provide evidence-based recommendations for prescribing an optimal diet for PCOS women.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>IRCT20200912048693N3, Trial registered 2022\u201312-14.<\/jats:p>\n                <jats:p><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.irct.ir\/trial\/67548\">https:\/\/www.irct.ir\/trial\/67548<\/jats:ext-link><\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13063-023-07569-6","type":"journal-article","created":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T05:01:28Z","timestamp":1691557288000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["A comparison of the portfolio low-carbohydrate diet and the ketogenic diet in overweight and obese women with polycystic ovary syndrome: study protocol for a randomized controlled trial"],"prefix":"10.1186","volume":"24","author":[{"given":"Maryam Sharifi","family":"Najafabadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalal","family":"Moludi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahya","family":"Salimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9886-0054","authenticated-orcid":false,"given":"Amir","family":"Saber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,9]]},"reference":[{"issue":"4","key":"7569_CR1","doi-asserted-by":"publisher","first-page":"261","DOI":"10.4103\/jhrs.JHRS_95_18","volume":"13","author":"R Deswal","year":"2020","unstructured":"Deswal R, et al. The prevalence of polycystic ovary syndrome: a brief systematic review. J Human Reprod Sci. 2020;13(4):261.","journal-title":"J Human Reprod Sci"},{"issue":"3","key":"7569_CR2","doi-asserted-by":"publisher","first-page":"e1071","DOI":"10.1210\/clinem\/dgaa839","volume":"106","author":"KM Hoeger","year":"2021","unstructured":"Hoeger KM, Dokras A, Piltonen T. Update on PCOS: consequences, challenges, and guiding treatment. J Clin Endocrinol Metab. 2021;106(3):e1071\u201383.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"7569_CR3","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","volume":"97","author":"BC Fauser","year":"2012","unstructured":"Fauser BC, et al. Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril. 2012;97(1):28-38. e25.","journal-title":"Fertil Steril"},{"issue":"7","key":"7569_CR4","doi-asserted-by":"publisher","first-page":"6213","DOI":"10.3390\/ijms24076213","volume":"24","author":"V Unfer","year":"2023","unstructured":"Unfer V, Dinicola S, Russo M. A PCOS paradox: does inositol therapy find a rationale in all the different phenotypes? Int J Mol Sci. 2023;24(7):6213.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"7569_CR5","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.3390\/biomedicines11061759","volume":"11","author":"V Unfer","year":"2023","unstructured":"Unfer V, et al. Treatment with myo-inositol does not improve the clinical features in all PCOS phenotypes. Biomedicines. 2023;11(6):1759.","journal-title":"Biomedicines"},{"issue":"1","key":"7569_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12958-016-0173-x","volume":"14","author":"V De Leo","year":"2016","unstructured":"De Leo V, et al. Genetic, hormonal and metabolic aspects of PCOS: an update. Reprod Biol Endocrinol. 2016;14(1):1\u201317.","journal-title":"Reprod Biol Endocrinol"},{"key":"7569_CR7","doi-asserted-by":"crossref","unstructured":"Bruni V, Capozzi A, Lello S. The Role of Genetics, Epigenetics and Lifestyle in Polycystic Ovary Syndrome Development: the State of the Art. Reprod Sci. 2022;29(3):668\u201379.","DOI":"10.1007\/s43032-021-00515-4"},{"issue":"3","key":"7569_CR8","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1093\/humrep\/deac001","volume":"37","author":"U Ezeh","year":"2022","unstructured":"Ezeh U, Pisarska M, Azziz R. Association of severity of menstrual dysfunction with hyperinsulinemia and dysglycemia in polycystic ovary syndrome. Hum Reprod. 2022;37(3):553\u201364.","journal-title":"Hum Reprod"},{"key":"7569_CR9","doi-asserted-by":"crossref","unstructured":"Cincione IR, Graziadio C, Marino F, Vetrani C, Losavio F, Savastano S, Colao A, Laudisio D. Short-time effects of ketogenic diet or modestly hypocaloric Mediterranean diet on overweight and obese women with polycystic ovary syndrome. J Endocrinol Invest. 2023;46(4):769\u201377.","DOI":"10.1007\/s40618-022-01943-y"},{"issue":"1","key":"7569_CR10","doi-asserted-by":"publisher","first-page":"e3464","DOI":"10.1002\/dmrr.3464","volume":"38","author":"A Krentowska","year":"2022","unstructured":"Krentowska A, Kowalska I. Metabolic syndrome and its components in different phenotypes of polycystic ovary syndrome. Diabetes Metab Res Rev. 2022;38(1):e3464.","journal-title":"Diabetes Metab Res Rev"},{"key":"7569_CR11","doi-asserted-by":"publisher","first-page":"9240569","DOI":"10.1155\/2022\/9240569","volume":"2022","author":"Y Xu","year":"2022","unstructured":"Xu Y, Qiao J. Association of insulin resistance and elevated androgen levels with polycystic ovarian syndrome (PCOS): a review of literature. J Healthc Eng. 2022;2022:9240569.","journal-title":"J Healthc Eng"},{"issue":"2","key":"7569_CR12","doi-asserted-by":"publisher","first-page":"272","DOI":"10.21608\/ejhm.2020.70969","volume":"78","author":"TAE-S Ibrahim","year":"2020","unstructured":"Ibrahim TAE-S, Ali AE-S, Radwan ME-H. Lipid profile in women with polycystic ovary syndrome. EJHM. 2020;78(2):272\u20137.","journal-title":"EJHM"},{"issue":"1","key":"7569_CR13","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1515\/openhe-2022-0008","volume":"3","author":"M Zehravi","year":"2022","unstructured":"Zehravi M, Maqbool M, Ara I. Healthy lifestyle and dietary approaches to treating polycystic ovary syndrome: a review. Open Health. 2022;3(1):60\u20135.","journal-title":"Open Health"},{"issue":"10","key":"7569_CR14","doi-asserted-by":"publisher","first-page":"e13046","DOI":"10.1111\/obr.13046","volume":"21","author":"LJ Moran","year":"2020","unstructured":"Moran LJ, et al. Evidence summaries and recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome: lifestyle management. Obes Rev. 2020;21(10):e13046.","journal-title":"Obes Rev"},{"issue":"1","key":"7569_CR15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.pcad.2018.05.004","volume":"61","author":"L Chiavaroli","year":"2018","unstructured":"Chiavaroli L, et al. Portfolio dietary pattern and cardiovascular disease: a systematic review and meta-analysis of controlled trials. Prog Cardiovasc Dis. 2018;61(1):43\u201353.","journal-title":"Prog Cardiovasc Dis"},{"issue":"8","key":"7569_CR16","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.3390\/nu13082850","volume":"13","author":"AJ Glenn","year":"2021","unstructured":"Glenn AJ, et al. Development of a Portfolio diet score and its concurrent and predictive validity assessed by a food frequency questionnaire. Nutrients. 2021;13(8):2850.","journal-title":"Nutrients"},{"key":"7569_CR17","doi-asserted-by":"publisher","first-page":"4386401","DOI":"10.1155\/2019\/4386401","volume":"2019","author":"X Zhang","year":"2019","unstructured":"Zhang X, et al. The effect of low carbohydrate diet on polycystic ovary syndrome: a meta-analysis of randomized controlled trials. Int J Endocrinol. 2019;2019:4386401.","journal-title":"Int J Endocrinol"},{"issue":"9","key":"7569_CR18","doi-asserted-by":"publisher","first-page":"3373","DOI":"10.1210\/jc.2008-0751","volume":"93","author":"RL Thomson","year":"2008","unstructured":"Thomson RL, et al. The effect of a hypocaloric diet with and without exercise training on body composition, cardiometabolic risk profile, and reproductive function in overweight and obese women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2008;93(9):3373\u201380.","journal-title":"J Clin Endocrinol Metab"},{"issue":"16","key":"7569_CR19","doi-asserted-by":"publisher","first-page":"10429","DOI":"10.3390\/ijerph191610429","volume":"19","author":"C Zhou","year":"2022","unstructured":"Zhou C, et al. Ketogenic diet benefits to weight loss, glycemic control, and lipid profiles in overweight patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled trails. Int J Environ Res Public Health. 2022;19(16):10429.","journal-title":"Int J Environ Res Public Health"},{"key":"7569_CR20","doi-asserted-by":"publisher","first-page":"108941","DOI":"10.1016\/j.jnutbio.2022.108941","volume":"102","author":"Y-J Hsu","year":"2022","unstructured":"Hsu Y-J, Huang C-C, Lin C-I. The effect of a low carbohydrate ketogenic diet with or without exercise on postpartum weight retention, metabolic profile and physical activity performance in postpartum mice. J Nutr Biochem. 2022;102:108941.","journal-title":"J Nutr Biochem"},{"issue":"1","key":"7569_CR21","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12967-020-02277-0","volume":"18","author":"A Paoli","year":"2020","unstructured":"Paoli A, et al. Effects of a ketogenic diet in overweight women with polycystic ovary syndrome. J Transl Med. 2020;18(1):104.","journal-title":"J Transl Med"},{"issue":"23","key":"7569_CR22","doi-asserted-by":"publisher","first-page":"12490","DOI":"10.3390\/ijerph182312490","volume":"18","author":"RI Cincione","year":"2021","unstructured":"Cincione RI, et al. Effects of mixed of a ketogenic diet in overweight and obese women with polycystic ovary syndrome. Int J Environ Res Public Health. 2021;18(23):12490.","journal-title":"Int J Environ Res Public Health"},{"issue":"3","key":"7569_CR23","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1111\/jog.14650","volume":"47","author":"J Li","year":"2021","unstructured":"Li J, et al. Ketogenic diet in women with polycystic ovary syndrome and liver dysfunction who are obese: a randomized, open-label, parallel-group, controlled pilot trial. J Obstet Gynaecol Res. 2021;47(3):1145\u201352.","journal-title":"J Obstet Gynaecol Res"},{"issue":"6","key":"7569_CR24","doi-asserted-by":"publisher","first-page":"101894","DOI":"10.1016\/j.jogoh.2020.101894","volume":"50","author":"SL Fong","year":"2021","unstructured":"Fong SL, Douma A, Verhaeghe J. Implementing the international evidence-based guideline of assessment and management of polycystic ovary syndrome (PCOS): how to achieve weight loss in overweight and obese women with PCOS? J Gynecol Obstet Hum Reprod. 2021;50(6):101894.","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"7569_CR25","doi-asserted-by":"publisher","first-page":"876620","DOI":"10.3389\/fnut.2022.876620","volume":"9","author":"S Mei","year":"2022","unstructured":"Mei S, et al. Mediterranean diet combined with a low-carbohydrate dietary pattern in the treatment of overweight polycystic ovary syndrome patients. Front Nutr. 2022;9:876620.","journal-title":"Front Nutr"},{"issue":"8","key":"7569_CR26","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.3390\/nu13082850","volume":"13","author":"AJ Glenn","year":"2021","unstructured":"Glenn AJ, et al. Development of a Portfolio diet score and its concurrent and predictive validity assessed by a food frequency questionnaire. Nutrients. 2021;13(8):2850.","journal-title":"Nutrients"},{"issue":"4","key":"7569_CR27","first-page":"396","volume":"12","author":"SA Bilsborough","year":"2003","unstructured":"Bilsborough SA, Crowe TC. Low-carbohydrate diets: what are the potential short-and long-term health implications? Asia Pac J Clin Nutr. 2003;12(4):396\u2013404.","journal-title":"Asia Pac J Clin Nutr"},{"key":"7569_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-019-2104-z","volume":"17","author":"G Muscogiuri","year":"2019","unstructured":"Muscogiuri G, et al. The management of very low-calorie ketogenic diet in obesity outpatient clinic: a practical guide. J Transl Med. 2019;17:1\u20139.","journal-title":"J Transl Med"},{"issue":"12","key":"7569_CR29","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3390\/antiox8120643","volume":"8","author":"A Valenzano","year":"2019","unstructured":"Valenzano A, et al. Effects of very low calorie ketogenic diet on the orexinergic system, visceral adipose tissue, and ROS production. Antioxidants. 2019;8(12):643.","journal-title":"Antioxidants"},{"issue":"9","key":"7569_CR30","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1093\/humrep\/des199","volume":"27","author":"F Bazarganipour","year":"2012","unstructured":"Bazarganipour F, et al. Psychometric properties of the Iranian version of modified polycystic ovary syndrome health-related quality-of-life questionnaire. Hum Reprod. 2012;27(9):2729\u201336.","journal-title":"Hum Reprod"},{"issue":"3","key":"7569_CR31","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/cen.13389","volume":"87","author":"M Amiri","year":"2017","unstructured":"Amiri M, et al. Association between biochemical hyperandrogenism parameters and Ferriman-Gallwey score in patients with polycystic ovary syndrome: a systematic review and meta-regression analysis. Clin Endocrinol (Oxf). 2017;87(3):217\u201330.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"7569_CR32","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/j.1365-2265.2007.02742.x","volume":"66","author":"H Ching","year":"2007","unstructured":"Ching H, Burke V, Stuckey B. Quality of life and psychological morbidity in women with polycystic ovary syndrome: body mass index, age and the provision of patient information are significant modifiers. Clin Endocrinol. 2007;66(3):373\u20139.","journal-title":"Clin Endocrinol"},{"issue":"9","key":"7569_CR33","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1093\/humrep\/dey256","volume":"33","author":"HJ Teede","year":"2018","unstructured":"Teede HJ, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018;33(9):1602\u201318.","journal-title":"Hum Reprod"},{"issue":"4","key":"7569_CR34","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.jand.2012.11.018","volume":"113","author":"LJ Moran","year":"2013","unstructured":"Moran LJ, et al. Dietary composition in the treatment of polycystic ovary syndrome: a systematic review to inform evidence-based guidelines. J Acad Nutr Diet. 2013;113(4):520\u201345.","journal-title":"J Acad Nutr Diet"},{"issue":"10","key":"7569_CR35","doi-asserted-by":"publisher","first-page":"3346","DOI":"10.1210\/clinem\/dgaa425","volume":"105","author":"Y Shang","year":"2020","unstructured":"Shang Y, et al. Effect of diet on insulin resistance in polycystic ovary syndrome. J Clin Endocrinol Metab. 2020;105(10):3346\u201360.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"7569_CR36","doi-asserted-by":"publisher","first-page":"E751","DOI":"10.1152\/ajpendo.00745.2009","volume":"298","author":"NB Ruderman","year":"2010","unstructured":"Ruderman NB, et al. AMPK and SIRT1: a long-standing partnership? Am J Physiol Endocrinol Metab. 2010;298(4):E751-60.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"7569_CR37","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.3390\/ijerph19031336","volume":"19","author":"J Parker","year":"2022","unstructured":"Parker J, et al. Polycystic ovary syndrome: an evolutionary adaptation to lifestyle and the environment. Int J Environ Res Public Health. 2022;19(3):1336.","journal-title":"Int J Environ Res Public Health"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07569-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-023-07569-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07569-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T20:04:34Z","timestamp":1700251474000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-023-07569-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,9]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["7569"],"URL":"https:\/\/doi.org\/10.1186\/s13063-023-07569-6","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,9]]},"assertion":[{"value":"21 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This trial was approved by the Ethics Committee of Kermanshah University of medical sciences with code No. IR.KUMS.REC.1401.404 and conducted in accordance with the Declaration of Helsinki. In addition, all women will give written informed consent before participating in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"The authors declare that they do not have competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"509"}}